candesartan has been researched along with Atypical Cluster Headache in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty (40) patients with episodic cluster headache (ICHD-2) were recruited and randomised over a five-year period to placebo or 16 mg candesartan in the first week, and placebo or 32 mg candesartan in the second and third week." | 2.78 | Randomised trial on episodic cluster headache with an angiotensin II receptor blocker. ( Bøe, MG; Dahløf, C; Jansson, SO; Monstad, I; Salvesen, R; Stovner, LJ; Tjensvoll, AB; Tronvik, E; Wienecke, T; Zwart, JA, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tronvik, E | 1 |
| Wienecke, T | 1 |
| Monstad, I | 1 |
| Dahløf, C | 1 |
| Bøe, MG | 1 |
| Tjensvoll, AB | 1 |
| Salvesen, R | 1 |
| Zwart, JA | 1 |
| Jansson, SO | 1 |
| Stovner, LJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prophylactic Treatment of Episodic Cluster Headache With an Angiotensin II Receptor Blocker (Candesartan Cilexetil); a Randomized, Placebo Controlled Parallel Study[NCT00184587] | Phase 2 | 40 participants (Actual) | Interventional | 2005-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for candesartan and Atypical Cluster Headache
| Article | Year |
|---|---|
Randomised trial on episodic cluster headache with an angiotensin II receptor blocker.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Cluster Headache | 2013 |